Delivery Order SPE2DR25D1103-SPE2DR26FE168
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,746.02 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on December 10, 2025, with completion scheduled for December 11, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $10,016.78 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed price contract, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $17,097.43 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-competitive delivery order is issued under a firm fixed price arrangement and represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to the federal government. The work will be performed at the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $31,043.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 8, 2025. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability...
- The Defense Logistics Agency awarded a delivery order valued at $3,691.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on November 17, 2025, with completion expected by November 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery falls within...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $30,943.32 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on September 11, 2025, with completion expected by September 12, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $24,148.65 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pens on November 18, 2025, with a completion date of November 19, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location and supports the military...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE168Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,571.34 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on December 2, 2025. This competitive delivery order, utilizing firm fixed pricing with no set-aside designation, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery vehicle with DLA Troop Support Medical (contract SPE2DX) that extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medications and medical commodities to support military healthcare systems and federal medical procurement needs. The Zepbound order represents one of numerous pharmaceutical deliveries the company fulfills through this prime vendor arrangement, which enables flexible sourcing of specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 12/1/25 |